ARTELO BIOSCIENCES, INC. Earnings Per Share, Basic and Diluted
ARTELO BIOSCIENCES, INC. (ARTL) reported Earnings Per Share, Basic and Diluted of -$0.12 per share for the 4-month period ending 2021-12-31, per its 10-KT filed 2022-03-21.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-21
- ARTELO BIOSCIENCES, INC. earnings per share, basic and diluted for the quarter ending 2021-11-30 was -$0.08.
- ARTELO BIOSCIENCES, INC. earnings per share, basic and diluted for the quarter ending 2021-08-31 was -$0.08.
- ARTELO BIOSCIENCES, INC. earnings per share, basic and diluted for the quarter ending 2021-05-31 was -$0.10.
- ARTELO BIOSCIENCES, INC. earnings per share, basic and diluted for the quarter ending 2021-02-28 was -$0.11.
- ARTELO BIOSCIENCES, INC. earnings per share, basic and diluted for fiscal 2021 was -$0.40.
- ARTELO BIOSCIENCES, INC. earnings per share, basic and diluted for fiscal 2020 was -$1.26.
- ARTELO BIOSCIENCES, INC. earnings per share, basic and diluted for fiscal 2019 was -$1.00.
- ARTELO BIOSCIENCES, INC. earnings per share, basic and diluted for fiscal 2018 was -$0.23.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 4 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$0.12 10-KT · filed 2022-03-21 | ||||||
| 2021-11-30 | -$0.08 10-Q · filed 2022-01-12 | ||||||
| 2021-08-31 | -$0.08 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$0.40 10-KT · filed 2022-03-21 | |||||
| 2021-05-31 | -$0.10 10-Q · filed 2021-07-12 | -$0.33 10-Q · filed 2021-07-12 | |||||
| 2021-02-28 | -$0.11 10-Q · filed 2021-04-13 | -$0.24 10-Q · filed 2021-04-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2022-03-21 | -$0.00 derived: net income ÷ weighted average shares · filed 2022-03-21 | |||
| 2020-12-31 | -$0.18 10-KT · filed 2022-03-21 | ||||||
| 2020-11-30 | -$0.14 10-Q · filed 2022-01-12 | -$0.00 derived: net income ÷ weighted average shares · filed 2022-03-21 | -$0.00 derived: net income ÷ weighted average shares · filed 2022-03-21 | -$0.00 derived: net income ÷ weighted average shares · filed 2022-03-21 | |||
| 2020-08-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2022-03-21 | -$0.00 derived: net income ÷ weighted average shares · filed 2022-03-21 | -$0.00 derived: net income ÷ weighted average shares · filed 2022-03-21 | -$1.26 10-KT · filed 2022-03-21 | |||
| 2020-05-31 | -$0.27 10-Q · filed 2021-07-12 | -$0.67 derived: net income ÷ weighted average shares · filed 2021-07-12 | -$1.06 10-Q · filed 2021-07-12 | -$1.35 derived: net income ÷ weighted average shares · filed 2021-07-12 | |||
| 2020-02-29 | -$0.40 10-Q · filed 2021-04-13 | -$0.79 10-Q · filed 2021-04-13 | -$1.08 derived: net income ÷ weighted average shares · filed 2021-07-12 | -$1.31 derived: net income ÷ weighted average shares · filed 2021-07-12 | |||
| 2019-11-30 | -$0.39 10-Q · filed 2021-01-14 | -$0.68 derived: net income ÷ weighted average shares · filed 2021-07-12 | -$0.89 derived: net income ÷ weighted average shares · filed 2021-07-12 | -$0.49 derived: net income ÷ weighted average shares · filed 2021-07-12 | |||
| 2019-08-31 | -$0.28 derived: net income ÷ weighted average shares · filed 2020-11-04 | -$0.47 derived: net income ÷ weighted average shares · filed 2020-11-04 | -$0.24 derived: net income ÷ weighted average shares · filed 2020-11-04 | -$1.00 10-K · filed 2020-11-04 | |||
| 2019-05-31 | -$0.17 10-Q · filed 2020-07-13 | -$0.09 derived: net income ÷ weighted average shares · filed 2020-07-13 | -$0.70 10-Q · filed 2020-07-13 | -$0.22 derived: net income ÷ weighted average shares · filed 2020-07-13 | |||
| 2019-02-28 | -$0.03 derived: net income ÷ weighted average shares · filed 2020-07-13 | -$0.07 derived: net income ÷ weighted average shares · filed 2020-04-13 | -$0.15 derived: net income ÷ weighted average shares · filed 2020-07-13 | -$0.19 derived: net income ÷ weighted average shares · filed 2020-07-13 | |||
| 2018-11-30 | -$0.04 10-Q · filed 2019-01-14 | -$0.13 derived: net income ÷ weighted average shares · filed 2020-07-13 | -$0.17 derived: net income ÷ weighted average shares · filed 2020-07-13 | -$0.24 derived: net income ÷ weighted average shares · filed 2020-07-13 | |||
| 2018-08-31 | -$0.14 derived: net income ÷ weighted average shares · filed 2019-12-18 | -$0.14 derived: net income ÷ weighted average shares · filed 2019-12-18 | -$0.21 derived: net income ÷ weighted average shares · filed 2019-12-18 | -$0.23 10-K · filed 2018-11-29 | |||
| 2018-05-31 | -$0.05 10-Q · filed 2018-07-13 | -$0.11 derived: net income ÷ weighted average shares · filed 2019-07-15 | -$0.14 10-Q · filed 2018-07-13 | -$0.15 derived: net income ÷ weighted average shares · filed 2019-07-15 | |||
| 2018-02-28 | -$0.07 10-Q/A · filed 2018-05-14 | -$0.05 10-Q · filed 2018-04-16 | -$0.10 10-Q/A · filed 2018-05-14 | -$0.08 10-Q · filed 2018-04-16 | -$0.11 derived: net income ÷ weighted average shares · filed 2019-07-15 | -$0.12 derived: net income ÷ weighted average shares · filed 2019-07-15 | |
| 2017-11-30 | -$0.02 10-Q · filed 2019-01-14 | -$0.04 derived: net income ÷ weighted average shares · filed 2019-07-15 | -$0.05 derived: net income ÷ weighted average shares · filed 2019-07-15 | -$0.05 derived: net income ÷ weighted average shares · filed 2019-07-15 | |||
| 2017-08-31 | -$0.01 derived: net income ÷ weighted average shares · filed 2018-11-29 | -$0.02 derived: net income ÷ weighted average shares · filed 2018-11-29 | -$0.02 derived: net income ÷ weighted average shares · filed 2018-11-29 | -$0.03 10-K · filed 2018-11-29 | |||
| 2017-05-31 | -$0.01 10-Q · filed 2018-07-13 | -$0.01 derived: net income ÷ weighted average shares · filed 2018-07-13 | -$0.01 10-Q · filed 2018-07-13 | -$0.02 derived: net income ÷ weighted average shares · filed 2018-07-13 | |||
| 2017-02-28 | $0.00 10-Q/A · filed 2018-05-14 | $0.00 10-Q/A · filed 2018-05-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-05-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-05-14 | |||
| 2016-11-30 | $0.00 10-Q/A · filed 2018-03-21 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-03-21 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-03-21 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-03-21 | |||
| 2016-08-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-11-29 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-11-29 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-11-29 | $0.00 10-K · filed 2017-11-29 | |||
| 2016-05-31 | $0.00 10-Q · filed 2017-07-21 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-07-21 | $0.00 10-Q · filed 2017-07-21 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-07-21 | |||
| 2016-02-29 | $0.00 10-Q · filed 2017-04-14 | $0.00 10-Q · filed 2017-04-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-04-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-04-14 | |||
| 2015-11-30 | $0.00 10-Q · filed 2017-01-10 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-01-10 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-01-10 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-01-10 | |||
| 2015-08-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2016-11-29 | -$0.00 derived: net income ÷ weighted average shares · filed 2016-11-29 | -$0.00 derived: net income ÷ weighted average shares · filed 2016-11-29 | $0.00 10-K · filed 2016-11-29 | |||
| 2015-05-31 | $0.00 10-Q · filed 2016-07-05 | -$0.00 derived: net income ÷ weighted average shares · filed 2016-07-05 | $0.00 10-Q · filed 2016-07-05 | -$0.00 derived: net income ÷ weighted average shares · filed 2016-07-05 | |||
| 2015-02-28 | $0.00 10-Q · filed 2016-04-01 | $0.00 10-Q · filed 2016-04-01 | -$0.00 derived: net income ÷ weighted average shares · filed 2016-01-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2016-01-14 | |||
| 2014-11-30 | $0.00 10-Q · filed 2016-01-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2016-01-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2016-01-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2016-01-14 | |||
| 2014-08-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2015-12-11 | -$0.00 derived: net income ÷ weighted average shares · filed 2015-12-11 | -$0.00 derived: net income ÷ weighted average shares · filed 2015-12-11 | $0.00 10-K · filed 2015-12-11 | |||
| 2014-05-31 | $0.00 10-Q · filed 2015-07-15 | -$0.00 derived: net income ÷ weighted average shares · filed 2015-07-15 | -$0.01 10-Q · filed 2015-07-15 | ||||
| 2014-02-28 | -$0.07 10-Q · filed 2015-04-14 | -$0.07 10-Q · filed 2015-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |